Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novartis -- Ignore unavailable to you. Want to Upgrade?

To: Tom Wilkes who wrote (125)	12/15/1997 6:30:00 PM
From: Sonki	Read Replies (1) \| Respond to of 296

great ! welcome aboard. did u get saphy yet? it's on a pull back. orcl took a dive. i don't have efii yet, but i m thinking aobut it right now. should do well by end of next yr.

To: Tom Wilkes who wrote (125)	12/20/1997 9:14:00 AM
From: Alfred W. Post	Read Replies (3) \| Respond to of 296

I am new to this thread - but not new to Novartis. Bought into tit in Spring 97 and am happy to have already a book gain of abot 32% (counting in Swiss Francs). Someone in the Merck thread asked about the relative performance Merck vs Novartis (easily won by Novartis - you can read about it in the Merck thread and despite the objection from someone else) and also about what is in the pipeline of Novartis after the Dec. 3rd. news from Merck and their full pipline, which caused the stock of Merck to jump. Well I had some difficulties to get an answer to many questions until I finally found the right person to contact. His E-Mail address is wolfgang.kirchmayr@group.novartis.com Upon request I just received in the mail a one pound publication dated October 97, which was made for a presentation in London at that time. It is quite all inclusive and you can order a copy for yourself by addreeing Mr. Kirchmayr. You might refer to my discussion with him. I told him I would broadcast this in Silicon Investor, which he did not know. However he was very specific in mentioning that they are very carful not to tell anybody anything that is not available to the public at large. You know fear of insider information suits. Hope this will help yours Fred from Switzerland